|
Report
|
Conditions recommended for treatment in clinical trials of smoked marijuana
|
Promising targets for cannabinoid drugs
|
Recommended research on potential harms of marijuana and cannabinoids?
|
Use of whole and/or smoked marijuana as medicine
|
Primary goals of cannabinoid drug development
|
|
Institute of Medicine2
|
Various, including nausea and vomiting, wasting, pain
|
Various, including nausea and vomiting, wasting, pain
|
Yes, especially on smoking-related harms
|
Whole marijuana is not a modern medicine
|
Safe, reliable, rapid-onset delivery method for cannabinoids
|
|
House of Lords (U.K.)3
|
Multiple sclerosis, chronic pain
|
Not discussed
|
None recommended
|
Hazards of marijuana smoke noted
|
Rapid-onset, smoke-free delivery systems (e.g., inhalation, under the tongue, and rectal suppositories)
|
|
World Health Organization4
|
Not discussed
|
Nausea and vomiting; muscle spasticity
|
Various, including infertility, respiratory damage, immune dysfunction, schizophrenia, and “amotivational syndrome”
|
Hazards of marijuana smoke noted
|
Not discussed
|
|
National Institutes of Health5 (U.S.)
|
Wasting, chemotherapy-induced nausea and vomiting, neurological and movement disorders, glaucoma
|
Nausea and vomiting, neuropathy, possibly muscle spasticity, certain dystonias and epilepsy
|
None recommended
|
Should be held to same standards of safety and efficacy as other FDA-approved drugs
|
Smoke-free inhaled delivery systems for marijuana and cannabinoids
|
|
British Medical Association6
|
Not discussed
|
Muscle spasticity, neurodegenerative disorders, epilepsy
|
None recommended
|
Cigarettes and crude marijuana preparations should not be used
|
Novel cannabinoid analogs for new uses
|
|
American Medical Association7
|
Various, including AIDS, wasting, chemotherapy-induced nausea and vomiting, MS, spinal cord injury, neuropathy
|
Not discussed
|
None recommended
|
Not recommended
|
Smoke-free inhaled delivery system for marijuana and cannabinoids
|
